Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleReply to Simon, Shah et al, and Hartzema and Chen.AuthorsBartsch, Sarah M.; Umscheid, Craig A.; Fishman, Neil; Lee, Bruce Y.AbstractA response from the authors of the article "Is fidaxomicin worth the cost? An economic analysis, published in a 2013 issue of "Clinical Infectious Disease" is presented.SubjectsFIDAXOMICIN; MACROLIDE antibioticsPublicationClinical Infectious Diseases, 2014, Vol 58, Issue 4, p605ISSN1058-4838Publication typeLetter to the EditorDOI10.1093/cid/cit775